Trial Profile

A first pivotal study is a multi-center, randomized controlled trial evaluating SkinTE in the treatment of diabetic foot ulcers (DFU)

Status: Recruiting

Phase of Trial: Phase III

Latest Information Update: 26 Feb 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

20 Feb 2025 According to PolarityTE media release, over 75% patients enrolled with topline interim results expected in Q1 2025 and final results in Q1 2026.
03 Dec 2024 According to PolarityTE media release, the company expects to complete enrollment in the 1st half of 2025. The company has enrolled 65 subjects toward the target of 120 subjects for performing interim analysis on the trial's 12-week primary endpoint.
03 Dec 2024 According to a PolarityBio media release, the company has surpassed the interim enrollment target for SkinTE's Phase III Pivotal Study in the treatment of Wagner 1 Diabetic Foot Ulcers (COVER DFUS II).

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com